Specifics of Cryopreservation of Hydrogel Biopolymer Scaffolds with Encapsulated Mesenchymal Stem Cells
Author:
Egorikhina Marfa N.1ORCID, Rubtsova Yulia P.1ORCID, Linkova Daria D.1ORCID, Charykova Irina N.1, Farafontova Ekaterina A.1ORCID, Aleinik Diana Ya.1
Affiliation:
1. Federal State Budgetary Educational Institution of Higher Education, Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation (FSBEI HE PRMU MOH), 603600 Nizhny Novgorod, Russia
Abstract
The demand for regenerative medicine products is growing rapidly in clinical practice. Unfortunately, their use has certain limitations. One of these, which significantly constrains the widespread distribution and commercialization of such materials, is their short life span. For products containing suspensions of cells, this issue can be solved by using cryopreservation. However, this approach is rarely used for multicomponent tissue-engineered products due to the complexity of selecting appropriate cryopreservation protocols and the lack of established criteria for assessing the quality of such products once defrosted. Our research is aimed at developing a cryopreservation protocol for an original hydrogel scaffold with encapsulated MSCs and developing a set of criteria for assessing the quality of their functional activity in vitro. The scaffolds were frozen using two alternative types of cryocontainers and stored at either −40 °C or −80 °C. After cryopreservation, the external state of the scaffolds was evaluated in addition to recording the cell viability, visible changes during subsequent cultivation, and any alterations in proliferative and secretory activity. These observations were compared to those of scaffolds cultivated without cryopreservation. It was shown that cryopreservation at −80 °C in an appropriate type of cryocontainer was optimal for the hydrogels/adipose-derived stem cells (ASCs) tested if it provided a smooth temperature decrease during freezing over a period of at least three hours until the target values of the cryopreservation temperature regimen were reached. It was shown that evaluating a set of indicators, including the viability, the morphology, and the proliferative and secretory activity of the cells, enables the characterization of the quality of a tissue-engineered construct after its withdrawal from cryopreservation, as well as indicating the effectiveness of the cryopreservation protocol.
Funder
Ministry of Health of the Russian Federation
Subject
Polymers and Plastics,General Chemistry
Reference58 articles.
1. Zhang, X., and Williams, D.F. (2018, January 11–12). Definitions of Biomaterials for the Twenty-First Century. Proceedings of the Consensus Conference, Chengdu, China. 2. Del Bakhshayesh, A.R., Asadi, N., Alihemmati, A., Tayefi Nasrabadi, H., Montaseri, A., Davaran, S., Saghati, S., Akbarzadeh, A., and Abedelahi, A. (2019). An Overview of Advanced Biocompatible and Biomimetic Materials for Creation of Replacement Structures in the Musculoskeletal Systems: Focusing on Cartilage Tissue Engineering. J. Biol. Eng., 13. 3. Biru, E.I., Necolau, M.I., Zainea, A., and Iovu, H. (2022). Graphene Oxide–Protein-Based Scaffolds for Tissue Engineering: Recent Advances and Applications. Polymers, 14. 4. Extracellular Matrix Regulation of Stem Cell Fate;Smith;Curr. Stem Cell Rep.,2018 5. Nie, Y., Zhang, S., Liu, N., and Li, Z. (2016). Composition and Function of the Extracellular Matrix in the Human Body, IntechOpen.
|
|